Glabellar filler is one of the few injectable treatments where the anatomy, not the aesthetics, decides whether the procedure should happen at all. The area between the eyebrows sits directly over the supratrochlear and supraorbital arteries, has very little subcutaneous fat, and connects to the blood supply of the eye. This article covers how to tell whether your lines are even a filler problem, how the treatment compares with botulinum toxin, the risks that make this region different, and what to ask before agreeing to an injection.
Deciding whether the lines are dynamic or static
The vertical lines between the eyebrows usually start as dynamic lines that appear when you frown or concentrate, and only later leave a permanent trace that reads as looking tired or stressed.
There is a simple test. Place your fingers between the eyebrows and let your face relax completely. If the lines soften or disappear, the problem is muscle contraction, and botulinum toxin is the appropriate treatment rather than filler. If they remain etched with the face fully at rest, you have a static deficit, which is the only situation where a filler is considered at all.
If the lines are driven mainly by the procerus and corrugator supercilii muscles, adding volume masks the symptom while the underlying cause continues unchanged.
A checklist before considering the procedure
Even when the line is genuinely static, the following sequence is worth working through with a specialist:
- Assess the depth of the wrinkle with the face in a neutral expression.
- Have the vascular path near the nasal bridge and the supraorbital notch mapped.
- Confirm whether there is any history of previous surgery or scarring in the frontal area.
- Establish whether the skin thickness in the glabella can carry the volume without visible lumpiness.
If the lines are caused mainly by heavy skin drooping, filler tends to produce a bloated appearance rather than a rejuvenated one. In that situation a structural approach such as an endoscopic forehead lift usually gives a more satisfying result than any volume-based injectable.
Filler compared with botulinum toxin
| Aspect | Botulinum toxin | Glabellar filler |
|---|---|---|
| Mechanism | Stops repetitive muscle contraction | Physically lifts the depression |
| Best suited to | Dynamic lines that soften at rest | Static lines etched at rest |
| Predictability | High | Depends on depth and volume placed |
| Main risk | Temporary asymmetry | Vascular occlusion, tissue necrosis |
| Duration | Temporary, requires repeat schedule | Longer, harder to reverse cleanly |
The most common mistake is assuming filler can replace the muscle-relaxing effect of toxin. If both are used, the muscles should be treated first. Reversing the order means the filler is subjected to continuous pulling and squeezing from the underlying muscles, which can displace it or create uneven bumps within a few weeks.
Most dermatologists advise against thick, high-crosslinking fillers in this region specifically because of the vascular occlusion risk.
The risks that make this region different
The complication that matters most is tissue necrosis caused by accidental injection into the supratrochlear or supraorbital arteries. These vessels supply the skin near the bridge of the nose and forehead, so an occlusion is a genuine emergency rather than a cosmetic disappointment.
Even a technically perfect procedure can leave bruising or swelling lasting up to seven days, and some patients report heaviness or tightness for several weeks as the hyaluronic acid integrates into the dense, inflexible tissue.
Volume precision matters more here than almost anywhere else on the face. With very little subcutaneous fat, the product sits close to the bone under tight skin, and as little as 0.2ml placed incorrectly can create an unnatural ridge that becomes obvious in bright, direct lighting.
What to ask before agreeing to treatment
If you are in your thirties or forties and looking for a long-term result, the sequence that carries the least risk starts with optimising skincare and maintaining a consistent botulinum toxin schedule so the lines do not deepen further. Filler enters the conversation only if a permanent shadow remains after that.
When you do consult someone, ask two specific questions: which filler-free options they would recommend for your particular depth of wrinkling, and what their protocol is for managing a vascular complication. Clinics that offer ultrasound-guided injection or can describe an emergency protocol without hesitation are demonstrating that they treat this area as the high-risk zone it is.
Common questions about glabellar filler
Can filler replace botulinum toxin for frown lines?
No. Toxin reduces the muscle contraction that creates the line, while filler adds volume beneath it. If both are used, the toxin should be given first so the filler is not displaced by muscle movement.
How long does bruising last after treatment?
Bruising and swelling can last up to about seven days even when the injection is performed correctly, and a sensation of tightness in the area may persist for several weeks.
Why is the glabella considered higher risk than other areas?
It has very little subcutaneous fat and a dense supply of vessels that connect to the eye area. Injecting into the supratrochlear or supraorbital arteries can cause tissue necrosis, which is why conservative volumes and experienced injectors matter here.
Facial vascular structure does not change with aesthetic trends. Before treating a static glabellar line, it is worth deciding whether a modest improvement justifies the trade-off in one of the least forgiving areas of the face.
That’s a really helpful point about observing the muscle activity – I’ve noticed my forehead lines shift noticeably when I consciously furrow my brow, it’s a good reminder of how dynamic they are.
That ultrasound point is really key. I’ve read about how much variation there is between people’s facial anatomy, and it seems like a direct visualization would be the best way to avoid a miscalculation.